News & Press - BioFlorida, Inc.

News & Press

Read about recent events, essential information and the latest community news.

Scientific Advancements
Saturday, December 12, 2020 (0 Comments - view/add) U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COV » U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for...
Friday, December 11, 2020 (0 Comments - view/add) Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-1 » Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19 Friday, December...
Thursday, December 10, 2020 (0 Comments - view/add) Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Aut » Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for...
Monday, December 7, 2020 (0 Comments - view/add) AireHealth Announces FDA 510(k) Clearance of Connected Nebulizer for Patients with Respiratory Condi » AireHealth Announces FDA 510(k) Clearance of Connected Nebulizer for Patients with Respiratory Conditions...
Wednesday, December 2, 2020 (0 Comments - view/add) Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19 » Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19 Wednesday, December 02, 202...
Wednesday, December 2, 2020 (0 Comments - view/add) Resolve Therapeutics Publishes Positive Sjogren's Syndrome Clinical Trial Results » Resolve Therapeutics Publishes Positive Sjogren's Syndrome Clinical Trial Results ST. PETERSBURG, Fla. , Dec. 2, 2020...
Monday, November 30, 2020 (0 Comments - view/add) Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate » Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today...
Wednesday, November 25, 2020 (0 Comments - view/add) AIM Announces Milestone in COVID-19 Treatment and Prevention Efforts with First Patient Dosed in Stu » AIM Announces Milestone in COVID-19 Treatment and Prevention Efforts with First Patient Dosed in Study Evaluating Ampl...
Monday, November 23, 2020 (0 Comments - view/add) AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 » AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 23 November 2020 07:00 GMT ...
Saturday, November 21, 2020 (0 Comments - view/add) Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to » November 21, 2020 at 7:56 PM EST...
Friday, November 20, 2020 (0 Comments - view/add) Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 » Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine...
Monday, November 16, 2020 (0 Comments - view/add) Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analys » Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE...
Thursday, November 12, 2020 (0 Comments - view/add) Medtronic Launches InPen™ with Real-Time Guardian™ Connect CGM Data -- the First Integrated Smart In » Medtronic Launches InPen™ with Real-Time Guardian™ Connect CGM Data -- the First Integrated Smart Insulin Pen for People...
Thursday, November 12, 2020 (0 Comments - view/add) CG Oncology Announces First Patient Dosed in Phase 1b Study of Oncolytic Immunotherapy CG0070 in Com » CG Oncology Announces First Patient Dosed in Phase 1b Study of Oncolytic Immunotherapy CG0070 in Combination with OPDIVO...
Wednesday, November 11, 2020 (0 Comments - view/add) AGTC Reports Additional Positive Data from its Phase 1/2 Clinical Trial in Patients with X-Linked Re » AGTC Reports Additional Positive Data from its Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa...
Monday, November 9, 2020 (0 Comments - view/add) Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim An » Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase...
Monday, November 9, 2020 (0 Comments - view/add) Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for » Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of r...
Monday, November 2, 2020 (0 Comments - view/add) AIM ImmunoTech Announces PLOS ONE’s Publication of New Data Analyses Showing Importance of Disease D » AIM ImmunoTech Announces PLOS ONE’s Publication of New Data Analyses Showing Importance of Disease Duration on Amplig...
Wednesday, October 21, 2020 (0 Comments - view/add) Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment Per US FDA » Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment Per US FDA Cyclo Therapeutics will now proceed...
Wednesday, October 14, 2020 (0 Comments - view/add) Virtual Reality Brings the Future of Shoulder Arthroplasty to Surgeons with Catalyst OrthoScience, I » Virtual Reality Brings the Future of Shoulder Arthroplasty to Surgeons with Catalyst OrthoScience, Immertec Technologies...
Monday, October 12, 2020 (0 Comments - view/add) Dyadic Updates Market on COVID-19 Initiatives » Dyadic Updates Market on COVID-19 Initiatives C1 Expression of SARS-CoV-2 Monoclonal Antibody Achieved...
Thursday, October 8, 2020 (0 Comments - view/add) AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 'Long Haulers' in the AMP-511 ME/CFS Clinic » AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 'Long Haulers' in the AMP-511 ME/CFS Clinical Trial of Ampligen...
Thursday, October 8, 2020 (0 Comments - view/add) Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human » Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to...
Tuesday, October 6, 2020 (0 Comments - view/add) FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine » FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine Re-Affirms Plan...
Friday, October 2, 2020 (0 Comments - view/add) BioCurity Pharmaceuticals Inc. ('BioCurity') Announces Issuance of European Patent for Reduction of » BioCurity Pharmaceuticals Inc. ('BioCurity') Announces Issuance of European Patent for Reduction of Side Effects Caused...
Thursday, October 1, 2020 (0 Comments - view/add) SurGenTec® Announces First-of-its-Kind FDA Clearance for its 3D GraftRasp System™ Including Key Spin » SurGenTec® Announces First-of-its-Kind FDA Clearance for its 3D GraftRasp System™ Including Key Spine Indications...
Wednesday, September 30, 2020 (0 Comments - view/add) Breaking COVID-19’s ‘clutch’ to stop its spread » Breaking COVID-19’s ‘clutch’ to stop its spread Researchers engineer RNA-targeting compounds that disable the p...
Tuesday, September 29, 2020 (0 Comments - view/add) OrganaBio Launches Portfolio of Novel Perinatal Tissue-Derived Products to Spur Rapid Development of » OrganaBio Launches Portfolio of Novel Perinatal Tissue-Derived Products to Spur Rapid Development of Cell and Gene Therapi...
Monday, September 28, 2020 (0 Comments - view/add) Hologic wins EUA for COVID-19 test for asymptomatic people » Hologic wins EUA for COVID-19 test for asymptomatic people September 28, 2020 By Chris Newmarker Hologic ...
Thursday, September 24, 2020 (0 Comments - view/add) Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines » Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines September 24, 2020 During th...
Tuesday, September 22, 2020 (0 Comments - view/add) Jupiter Orphan Announces Federal Grant to ADVANCE JOTROL™ to Phase I Clinical Trial for Alzheimer's » Jupiter Orphan Announces Federal Grant to ADVANCE JOTROL™ to Phase I Clinical Trial for Alzheimer's JUPITER, Fla. , Sep...
Tuesday, September 15, 2020 (0 Comments - view/add) OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients » OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients MIAMI, Sept. 15, 2020 (GLOBE NEWSWIRE) -- OPKO...
Wednesday, September 9, 2020 (0 Comments - view/add) Case study describes unexpected diagnosis of one of the first cases of MIS-C in U.S. » Case study describes unexpected diagnosis of one of the first cases of MIS-C in U.S. Finding of multisystem inflammatory...
Thursday, September 3, 2020 (0 Comments - view/add) ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect » ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutral...
Tuesday, August 25, 2020 (0 Comments - view/add) Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY® » August 25, 2020 07:30 AM Eastern Daylight Time MONTREAL & BOCA RATON, Fla.--(...
View "All News Items" »

Member Sign In

Forgot your password?

Don't have a profile?